Evidence map›Paper›PMID 32973031›Full record

ArticleScience (New York, N.Y.)2020

Large-scale RNAi screening uncovers therapeutic targets in the parasite

Jipeng Wang, Carlos Paz, Gilda Padalino, Avril Coghlan, Zhigang Lu, Irina Gradinaru, Julie N R Collins, Matthew Berriman, Karl F Hoffmann, James J Collins

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
7.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Plant-Derived Terpenes as Emerging Therapeutics Against Schistosomiasis.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Loss of vitamin C biosynthesis protects from the pathology of a parasitic infection.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. A genome-scale drug discovery pipeline uncovers therapeutic targets and a unique p97 allosteric binding site inProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jipeng Wang *Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0003-0107-424X
Carlos Paz *Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA.ORCID 0000-0001-7277-4329
Gilda PadalinoInstitute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, Aberystwyth, Wales, UK.ORCID 0000-0001-8580-1293
Avril CoghlanWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.ORCID 0000-0002-2775-5951
Zhigang LuWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.ORCID 0000-0001-6553-5944
Irina GradinaruDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Julie N R CollinsDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA.
Matthew BerrimanWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.ORCID 0000-0002-9581-0377
Karl F HoffmannInstitute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University, Aberystwyth, Wales, UK.
James J CollinsDepartment of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA. jamesj.collins@utsouthwestern.edu.ORCID 0000-0001-5237-1004
Southwestern Medical Center · USAberystwyth University · GBWellcome Sanger Institute · GB

Funding

The Biology of Stem Cells in the Human Parasite Schistosoma MansoniR01AI121037 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI COLLINS, JAMES J · 2016 to 2025
$4.4M
Howard Hughes Medical InstituteNIAID NIH HHS HHSN272201700014CNIAID NIH HHS R01 AI121037Wellcome Trust
6 · The paper itself

Abstract

Schistosome parasites kill 250,000 people every year. Treatment of schistosomiasis relies on the drug praziquantel. Unfortunately, a scarcity of molecular tools has hindered the discovery of new drug targets. Here, we describe a large-scale RNA interference (RNAi) screen in adult

Indexed as

Molecular Targeted TherapyAnimalsAnthelminticsGenes, HelminthGenetic TestingHelminth ProteinsProtein Serine-Threonine KinasesRNA InterferenceSchistosoma mansoniSchistosomiasis mansoniTranscription, GeneticAnthelminticsHelminth ProteinsProtein Serine-Threonine Kinases

Identifiers

PMID32973031
PMCPMC7877197
OpenAlexW3087862169

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.